Activity of drug efflux transporters in tumor cells under hypoxic conditions

Advances in Experimental Medicine and Biology

Volumn 614, Issue , 2008, Pages 157-164

  Thews, Oliver ^a   Gassner, Birgit ^b   Kelleher, Debra K ^a   Gekle, Michael ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOPROTEIN P; LACTOSE; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL CELL; CELL PH; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOXIC CELL; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; TUMOR CELL;

EID: 84934439836     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74911-2_19     Document Type: Conference Paper

References (14)

1. A.H. Schinkel and J.W. Jonker. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55, 3-29 (2003).
2. S.V. Ambudkar, C. Kimchi-Sarfaty, Z.E. Sauna, and M.M. Gottesman. P-glycoprotein: from genomics to mechanism. Oncogene 22, 7468-7485 (2003).
3. T. Fojo and S. Bates. Strategies for reversing drug resistance. Oncogene 22, 7512-7523 (2003).
4. M.J. Siegsmund, C. Kreukler, A. Steidler, T. Nebe, K.U. Kohrmann, and P. Alken. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Urol. Res. 25, 35-41 (1997).
5. P. Vaupel, F. Kallinowski, and P. Okunieff. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465 (1989).
6. M. Höckel and P. Vaupel. Tumor hypoxia: definitions and current clinical, biological, and molecular aspects. J. Natl. Cancer Inst. 93, 266-276 (2001).
7. G. Lee and M. Piquette-Miller. Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays. J. Pharm. Sci. 92, 2152-2163 (2003).
8. H.H. Versteeg, E. Nijhuis, G.R. van den Brink, M. Evertzen, G.N. Pynaert, S.J. van Deventer, P.J. Coffer, and M.P. Peppelenbosch. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem. J. 350, 717-722 (2000).
9. O. Thews, B. Gassner, D.K. Kelleher, G. Schwerdt, and M. Gekle. Impact of extracellular acidity on the activity of p-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8, 143-152 (2006).
10. P. Vaupel, C. Schaefer, and P. Okunieff. Intracellular acidosis in murine fibrosarcomas coincides with ATP depletion, hypoxia, and high levels of lactate and total Pi. NMR Biomed. 7, 128-136 (1994).
11. R.H. Xu, H. Pelicano, Y. Zhou, J.S. Carew, L. Feng, K.N. Bhalla, M.J. Keating, and P. Huang. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65, 613-621 (2005).
12. B.C. Liang. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J. Neurooncol. 29, 149-155 (1996).
13. K. Sakata,T.T.Kwok, B.J.Murphy, K.R. Laderoute, G.R. Gordon, and R.M. Sutherland. Hypoxia-induced drug resistance: comparison to P-glycoprotein- associated drug resistance. Br. J. Cancer 64, 809-814 (1991).
14. K.M.Comerford, T.J. Wallace, J.Karhausen, N.A. Louis, M.C. Montalto, and S.P.Colgan. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387-3394 (2002).